| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.45 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |